MOBILE Management GmbH
MOBILE Management GmbH represents UBT SRL in Germany concerning MammoWave distribution and clinical trials within the leading University Hospitals in Germany.
Imago 7 Foundation is a consortium for scientific research in the field of magnetic resonance (MR); it is equipped the first and only 7.0 Tesla MR system in Italy.
DIGITEC, leader in software for medical imaging and digital innovation.
This partnerships concerns the risk assessment for electromagnetic fields radiated by medical devices such as electrosurgical-knife and magneto-therapy apparatus. In addition, MammoWave clinical trials have been activated at Foligno Hospital.
This partnerships concerns the definition of dedicated protocols for the measurements of electromagnetic fields, in working environments and hospital environments.
London South Bank University (LSBU)
UBT Srl activated an Industry Part Funded PhD with the Biomedical Engineering and Communications (BiMEC) Research Group, LSBU, focused on the optimization of the microwave apparatus for breast cancer detection and its extension to other diagnostic applications, such skin cancer detection and brain stroke imaging.
Recently, UBT Srl activated also a Matched Funded Post-Doctoral research fellowship focussed on Artificial Intelligence-AI. In September 2019, UBT became a full member of the London Southbank Innovation Centre, UK ( https://www.s-ici.com/members )
Azienda Ospedaliera di Perugia
The first MammoWave clinical trials have been activated at Perugia Hospital “Azienda Ospedaliera S. Maria della Misericordia”. Clinical trials are still ongoing.